Company / Shareholders' Equity
Emergent BioSolutions Inc. Shareholders' Equity History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$522.6M
FY2025
5-year range
$482.8M / $1.6B
FY2021-FY2025
Trend
+8.2%
vs FY2024
Sector context
#92 of 213
Health Care
What the data says
At $523M, Emergent BioSolutions Inc.'s shareholders' equity ranks #92 of 213 in the Health Care sector. Shareholders' Equity returned to growth in FY2025 after 3 years of decline, reaching $523M.
Based on SEC 10-K filings.
$523M in FY2025 with a 5-year CAGR of -18.5%.
Declined from $649M to $523M over the past 2 years.
Health Care sector context is included.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- -27.8%
- 5-Year CAGR
- -18.5%
- 10-Year CAGR
- -
Sector benchmark
#92 of 213 in Health CareTop 43% of 213This company $522.6M Sector average $2.5B
▼
-79.5% below sector average
Key checks
Key Insights
- 5-year CAGR of -18.5%, indicating a declining trend.
- In FY2025, shareholders' equity increased 8.2% year-over-year.
- Ranks #92 out of 213 companies in the Health Care sector.
- Peak shareholders' equity was recorded in FY2021.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $522.6M | +8.2% |
| FY2024 | $482.8M | -25.6% |
| FY2023 | $649.3M | -53.2% |
| FY2022 | $1.4B | -13.9% |
| FY2021 | $1.6B | +11.1% |
| FY2020 | $1.5B | +33.3% |
| FY2019 | $1.1B | +19.3% |
| FY2018 | $912.3M | +0.0% |
| FY2017 | $912.3M | +53.0% |
| FY2016 | $596.2M | -9.7% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026